Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03150693 |
| Title | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia |
| Recruitment | Suspended |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Alliance for Clinical Trials in Oncology |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |